Charity registration number 1084898 SYNCOPE TRUST AND REFLLX ANOXIC SEIZURES ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024
SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES LEGALAND ADMINISTRATIVE INFORMATION Trustees Dr. W P Whitehou5e Mrs C L Reid E Bateson Dr M Asgari Charbty number 1084898 Princlpal address TC Group Celixir House Straford Business & Technology Park Innovation Way, Banbury Road Strarford~upon-Avon Warwick5hire CV37 7GZ Independent examiner TC Group Celixir House Stratford Business & Technology Park Innovation Way, Banbury Road Stratford-upon-Avon Warwick5hire United Kingdom CV37 7GZ
SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES CONTENTS Page Trustees, report Independent examiner's report Statement of financial activities Balance sheet Notes to the fi.nancial statements 10.17
SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES TRUSTEES, REPORT FOR THE YEAR ENDED 31 DECEMBER 2024 The Trustees present their annu31 report and financial statements for the year ended 31 December 2024. The financial statements have been prepared in accordance with the accounting politles set out in notè I to the financial statements and comply with the Charity's Igoverning document], the Charities Act 2011 and "Accounting and Reporting by Charities.. Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FPS 1021" (effective l January 20191. Objeetives and artivitie5 The principal objective5 of the charity are.. To alleviate the effects of and provide support and information on, syncope and reflex 2nDxic seizures, to those in distress as a result of these sèilures. whether suffered by themselve5 or as a member of the family group. To advance the education of the medical profession and the general public on the subject of syncope and reflex anoxic seizures and its implication5 for the individual and family. To promote research into the management of syncope and reflex anoxic seizure and to publish the Uful results thereof and to support organisations promoting research into syncope and reflex seizures. There have been no changes to these objettives since the last annual report. Volunteers STARS utilises volunteers to a55i5t in our work. STARS Trustees review the aims, objective5 and the activities of the Charity each yèar. This report looks at what the Charity has achieved and the outcomes of its activities in the reporting period, January to December 2024. The review also helps to ensure that the Charity's aims, objectives and activities remain focused on it5 Stated purposes. There is no such thing as a simplefoint,. Syncope is a symptom not o condition,. take fainting to heart. Quotes that are synonymous with the campaign5 STARS has run over the years and which have been instrumental in raising awareness and reducing misdiagnosis. Our vision is that every patient with syncope received a corrett diagnosis and treatment. Our mi55ion is working together to improve the dlagnosis, treatment and quality of life for all tPose affetted by syncope. This year STARS celebrates its, 31st anniversary. Public benefit The Trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the Charity should undertake. The trustees confi'rm that they have complied with their duty under SeLtion 4 of the Charitie5 Art 2011 to have due regard to the Charity Commission's general guidance on public benefit.
SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES TRUSTEES. REPORT (CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024 Achievements and perfomiance Significant uctivities and achievements ugainst objectives STARS continues to be the only organisation globally dedicated to providing information, support, education and awareness on unexplained loss of consciousness, syncope, reflex anoxic seizures, POTS and related conditions. We are freq¢Jently requested to present at medical meetings, provide answers to schools about how to receive a child with RAS and to provide the necessary support to p3rent5, caregivers, and familie5 to help them better support the person living with the condition. Professor John B P Stephenson STARS Founding Patron, Professor John B P stephenson sadly passed away on 17 April 2024. The Charity is immensely grateful for all the support and commttment he provided over more than 30 years. It wa5 1978 when Prof Stephenson gave a name to the unexplained loss of consciousness young chlldren were experiencing. Reflex Anoxic Seizure5 IRASI. Until then, many children were being misdiagnosed with epilepsy and prescribed what would have been unnecessary anti-epilepb"c medication. It was Prof Stephenson who then asked whether we would like to start a small 'support group to help about ten families a year,. This was March 1993, and STARS was conceived. In 1994, he presented at the very first STARS Patrent Day. attended by 106 adults and 98 children. The children, some of whom artually had an RAS éttack on the day, were looked after In five creches by qualified Kilunteers. The Professor thought this was marvellous as it helped with his research. He was already becoming internationally recognised as a pioneer in paediatric neurology and until last year had published numerous papers and books. He kept his promise he made in 1993 to support STARS; he attended every patient day for the next 20 years and more and presented at the Heart Rhythm Congress. He also made a surprise entrance at the Palace ol Westminster for STARS 25" anniversary. He was very proud of STARS and all that we have achieved. He had a vision na child would be misdiagnosed with epilepsy as long as RAS was recognised and un(krstood by the medical profession. STARS will continue to SLtpport his work and ensure it has not been in vain.
SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES TRUSTEES, REPORT ICONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Supportiftg people living with Syncope, RAS and POTS STARS educational videos, resources, online forums and other information continue to deliver information, SUPPOrt, education, and awareness to all those affected by syncope and loss of consciousness. Webinars were produced with guidance and contributions from healthcare professionals, ensuring our material is up to date and informative for VARS audience. Over 109,000 individual views during 2024. A new RAS Discussion Guide wa5 also developed during the year. Virtual coffee mornings An opportunity to talk to patients, caregivers and family members sharing experiences, and where the STAR5 team can provide reassurance and guid3nce. DurinE 2024 STARS online meetings included topics such as- RAS- StartinE School and College held on the 04 July 2024 Llving with RAS and Syncope- STARS continued throughout 2024 with its 'Living With... series for patient video education on a range of subjetts which includes Living with RAS and Syncope. All of these are avail able online and are free to register to watch. Ralsing awareness of syncope and syncope-related conditions - World Heart Rhythm Weèk 2024 STARS collaborates and supports the World Heart Rhythm Week hosted in June each year and organised by its sister charity- Arihythmia Alliance. For WHRW2024 the theme was 'Act Smart, You Only Have One Heart'l Supporters were encouraged to rase awareness of syncope, highlighting that syncope is often overlooked, but it can be a warning sign of an underlying heart rhythm disorder. Early detection and proper diagnosis are key to preventing serious complications, and during the week STARS was able to ensure more people were aware of syncope as a potential symptom of an irregular heart rhythm, to seek medical advice if they or a loved one experienced nexplained 1055 of consciousness or have a history of Sudden cardiac death in the family, and to access STAR5 resources. We received support from thousands of individuals, organi5ations, and healthcare professional around the globe, resulting in Dur campaign reaching many millions of people.
SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES TRUSTEES. REPORT (CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024 Hostln8 events for both healthcare professionalsi patients, and caregiver5. STARS Patiertts Educational Day was held as part of the annu31 Heart Rhythm Congress èt the ICC in Birmingham. The day was well attended and, sessions included presentstion5 on the variou5 concerns relating to Situational Syncope, RAS /Syncope in the young, Cardiac Syncope, Complexity of Syncope in the elderly, and TiltTable resting. There w35 a live patient story which also included the opportunity for question5 and answers. All sessions were recorded and hosted online 50 those who could not attend in person could still access thi5 informati)n. Thi5 enables access throughout the year to all patients and care givers. STARS Patients Day provides the opportunity to hear the latest developments in syncope, and treatment options, from leading medical experts from the UK, USA, Canada, Europe and Monaco. STARS Symposla for healthcare professionals w35 hosted during the Heart Rhythm Congre55. Subjects covered were.. - Syncope: Driving and flyin& Syncope in the Workplace, Syncope.. Reaplife diagnostic tests in a modern syncope unit, Syncope in the emergency department, Syncope and genetic arrhythmias and Syncope epidemiology and natural history. Presented by speakers from Europe. Canada- Monaco; UK & USA. Resources New publications for 2024 include a RAS discussion guide which is availa ble online and in paper format. With a full listing of publications also available on our website www.stars.orE.uk Fundraislng During the current etonomic situ2tr.on STARS ha5 received significantly reducèd donations however we did see many more funéraisers during 2024 through JustGiving, adding a boost to our fund5. Monthly amounts were raised through lending of books organised by a STARS Trustee, and a Dr based in Glasgow raised money for STARS by cycling from Lands, End to John O Groats. STARS Helplifte STARS has received even more enquirie5 during 2024- the demand increases year on year, and we wlll continue to meet this demand and work to reduce the struggle to find an appropriate healthcare professional to diagnose correttly and to reduce the number of misdiagnoses for people living with these conditions. STARS continues to meet demand from patients, Caregivers, families, schools, colleges and universities, work environments and care homes plus healthcare profession315 and clinics seeking information. education, support and greater awareness. We plan for future years to be as successful as the previoL¢S 31 years and live in hope that a5 awareness increases $0 too will detection and diagnosis leading to better outcomes for all those impacted by these conditions. We must also focus on ensuring no matter where someone lives, they can access a service near to them. Currently with so few dedicated clinic5 It is a challenge for so many to find an expert Itxally. Communicating our work Effective communications are key to sharing the work that the Charity undertakes. RaisinB awareness of our website resources, and our use of social media are vital to gr¢wing patier)t Èngagement and awareness of syncope and unexplained loss of consclousness.
SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES TRUSTEES. REPORT (CONTINUED} FOR THE YEAR ENDED 31 DECEMBER 2024 Flnancial review The Charity has seen a decrease in income from £121,559 in 2023 to £106,975 in 2024. This 15 due to a decrease in donation income from £17.239 in 2023 to £14,068 in 2024 and a decrease in grant income from £103,667 in 2023 to £89,674 in 2024. Expenditure decreased from £79,302 in 2023 to £76,145 in 2024. The Charity's total funds increased by £30,830 to £636,150 in the financial year. The Trustee5 have a strategic and operational plan in place to ensure stability and growth, Reserve5 policy The Trustees have a policy of maintaining a level of unrestricted reserves which should ensure that there are adequate funds to meet anticipated future liabilities. In practice the Trustees consider that holding reserves equivalent to a minimum of 3 month5, core costs. excluding funds tied up in fixed assets should provide sufficient funds to respond to unexpected adverse changes in the Charity's funding or activities. This equates to a minimum of £15,000 based on the current leve15 of activity. The Trustees consider that the current level of unrestricted reserves is therefore adequate. Structure, governance and management Governing document The Charity is constituted under a Charity Commission Scheme and is registered Charity number 1084898. The Charity's activities are governed by a Declaration of Trust adopted on 24 November 2000. The Charity was granted charitable status on 6 February 2001. The Trustees who served during the year and up to the date of signature of the financial statement5 were.. Dr. W P Whitehouse Mrs CL Reid E Bateson Dr M Asgari Recruitment and appointment of trustee5 The management of the Charity is responsible of the Trustee5 who are elected and ctiopted under the term5 of the Trust deed. There must at all times be a minimum Df three Trustees in office. The first Trustees are entitled to hold office for life. New frustees are appointed by a re501ution passed by the TrL¢Stees in special meeting. Orgt7nisationol Structure The Trustees delegate the day to day management of the Charity to the Chief Executive and her support 5t3ff. Induction and training of trustees New Trustee5 undergo an orientation process to brief them on their legal obligations under Charity law the Charity's governing documents, the committee and decision making process, the business plan and reCt financial performance of the Charity. During the induction process they meet key employees and other trustees. Trustees are encouraged to attend appropriate external and internal training events which will asslst them in carrying out their role.
SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES TRUSTEES, REPORT (CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024 Ackn<Jwledgements STARS would like to acknowledge the various Trusts. Foundations and Medical Industry that 50 generously gave their support during the financial year. The Trustees would like to recognise the outstanding contribution made by Trudie Lobban in pursuit of sfARS goals and the significant and high impact achievements attained this year through her vision and determinatton. The Trustees would also like to acknowledge the commitment of the STARS team in their empathetic approach to the dellvery of STARS service throughout the year. Conntcted Charities Arrhythmia Alliance IAAI, a UK registered Charity, number 1107496 15 connected to STARS as an affiliate of the umbrella organisation. Atrial Fibrillation Association {AFAI, a UK registered charity, number 1122442 is connected to STARS 35 an affi'liate of the umbrella organisation. STARS US, Inc, a registered SOI{cl non profit organisation in the USA is connected to AFA as an affiliate of the umbrella organi5ation. The Trustee5' report was approved by the Board of Trustees. Mrsc LReid Tru5teÉ 20 August 2025
SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES I report to the Trustees on my examlnatfon of the financial statements of Syncope Trust and RefiexAnoxic Seizures (the Charityl for the year ended 31 December 2024. Responslbilities and basls of report As the Tru5tee5 of the Charity you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Art 2011 Ithe 2011 Act). I report in respect of my examlnation of the Charity'5 financial statements carried out under section 145 of the 2011 Act. In carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 14515)Ibl of the 2011 Act, Independent examiner's statement Your attention is drawn to the fact that the charlty has prepared financial statements in accordance with Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the U K and Republic of Ireland IFRS 1021 in preference to the Accounttng and Reporting bv Charitie5.' Statement of Recommended Practice issued on l April 2005 which is referred to in the eXtt regulations but has now been withdrawn. understsnd that this has been done in order for flnancial statements to provide a true and fair view in accordance with Generally Accepted Accounting Practice effective for reporting periods beginning on or after I January 2015. I have completed my examinatr"on. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect.. accounting records were not kept in respect of the Charity as required by sectfon 130 of the 2011 Act,. or the financial statements do not accord with those records,. or the financial statements do not comply with the applicable requirements concerning the fomi and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the account5 give a true and fair view which is not a matter considered a5 Part of an independent examination. I have no concerns and have come across no other matters in connection with the examination to whth attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached. TC Group Celixir House Stratford Business & Technology Park Innovation Way, Banbury Road Strarford-upon-Avon Warwickshire CV37 7GZ United Kingdom Dated: 20 August 2025
SYNCOPE TRusf AND REFLEX ANOXIC SEIZURES STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31 DECEMBER 2024 Unre5trlcted funds 2024 Unrestrlcted funds 2023 Notes Income from: Donations and legacies Charitable activities Investments 14,068 89,674 3,233 17,239 103,667 653 Total income 106,975 121,559 Expenditure on: Charitable attivities 76,145 79,302 Total expendlture 76,145 79,302 Net income and movement in funds 30,830 42,257 Reconciliation of funds: Fund balances at l January 2024 605,320 563,063 Fund balances at 31 December 2024 636,150 605,320 The ststement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuin£ attlvities.
SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES BALANCE SHEET AS AT 31 DECEMBER 2024 2024 2023 Notes Current assets Debtors Cash at bank and in hand 13 79,328 560,28Q 540,379 68,597 639,608 608,976 Creditors: amounts falling due withln one year 14 13,4581 13,6561 Net current assets 636,150 605,320 Net assets excluding penslon Ilabllity 636,150 605.320 The funds of the Charity Unrestricted funds 636,150 605,320 636,150 605,320 The financial statements were approved by the Trustees on 20 August 2025 Mrs C L Reid Trustee
SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Accounting policie5 Charlty information Syncope Trust and Reflex Anoxic Seizures is a unincorporated Chèrity. 1.1 Accounting eonventlon The financial statements have been prepared in accordance with the Charity's Igoverning documentl, the Charities Act 2011, FRS ID2 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" I'FRS 102.1 and the Charities SORP "Accounting and Reporting by Charitie5'. Statement of Recommended Practice appSicable to charities preparing their accounts in accordance with the Financral Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021" (effective l January 20191. The Charity is a Public Benefit Entity a5 detined by FRS 102. The Charity has taken advantage of the provisions in the SORP for rharities not to prepare a State ment of Cash Flows. The ftnancial statements have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a true and f31r view. This departure has involved following the Statement of Recommended Practrce for charities applying FRS 102 rather than the version of the Statement of Recommended Practice which is referred to in the Regulatr"ons but which has since been withdrawn. The financial statements are prepared in sterling, which is the functional currency of the Charity. Monetary amounts in these financial statements are rounded to the nearest £. The financial statements have been prepared under the historical cost convention. The principal aoounting policies adopted are set out beS0w. 1.2 Going concern At the time Df approving the finaF)cial statement5, the Trustees have a reasonable expectation that the Charity ha5 adequate resources to continue in oper2tr.onal existence for the foreseeable future. Thus the Trustees continue to adopt the going concern basis of accounting in preparing the financi31 statements, 1.3 Charitsble funds Unrestricted funds are available for USÈ at the discretion of the Trustee5 in furtherance of their charitable objectives. Restricted funds are subjed to specific conditions by donors or grantors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements. 1.4 Income Income is recognised when the Charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received. Cash donatr'ons are reco8nised on receipt. Other donation5 are recognised once the Charity ha5 been notified of the donation, unless performance conditr'ons require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant 15 recognised at the time of the donation. 10-
SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR EfiIDED 31 DECEMBER 2024 A¢¢ountlng poll¢les Icontintsed) Legacies are recognised on receipt or otherwise if the Charity has been notified of an Impending distribution. the amount is known, and receipt is expected. If the amount is not known. the legacy s treated a5 a contingent asset. 1.5 Expenditure Expenditure is recognised once there 15 a legal or constructive obli6ation to transfer economic bwefit to a third party, it is prob3ble that a transfer of economic benefits will be required in settlement. andthe amount of the obligation can be measured reliably. Expenditure is classtfi'ed by activity. The costs of each activity are made up of the total of dirert cost5 and shared costs, including 5UPPOrt C05ts involved in undertaking each activity. Direct costs attributaEAe to a single activity are allocated directly to that activity. Shared cost5 which contribute to more than one 3ctivity and support costs which are not attributable to a single activity are apportioned between those actwitie5 on a basts consistent with the use of resources. Central staff costs are allocated on the basis of time spent. and depreciation charges are allocated on the portion of the as5et'S Use. 1.6 Tangible fixed èssets Tangible fixed assets are initially measured at C05t and subsequently measured at CQ5t or valuation. net of depreciation and any impairment losses. Depreciation is recognised so as to write off the cost or valuation of a55ets less their residual value5 over their useful lives cn the following bases.. Fixtures and fittings 50% striaght line The gain or loss arising on the disposal of an 25set is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities. 1.7 Cash and cash equivalents Cash and cash equivalents include cash in hand. deposits held at call with banks, other short-term liquid investments WFth original maturities of three months or less. and bank overdrafts. Bank overdrafts are Shown within borrowings in current Ilabilities, 1.8 Financial instruments The Charity has elected to apply the provi5i0ns of Section 11 'Basic Financial Instruments, and Section 12 'Other Financial Instruments Issues, of FRS 102 to 311 of its financial instruments. Financial instruments are reco8nised in the Charity's balance sheet when the Charity becomes party to the contractual provisions of the instrument, Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there 15 an intention tosettle on a net ba515 or to realise the asset and settle the liébility simultaneously. 11
SYNCOPE TRusf AND REFLEX ANOXIC SEIZURES NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Accounting polictes {Continuedl Basicfinonclal assets Basic financial assets, which include debtors and cash and bank balances, are initially measured * transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a fi'nancing transaction, where the transaction is measured at the present value of the future receipts discounted 3t a market rate of interest. Financial assets c1855ified a5 receivable within one year are not amortised. Ba5icfinancial Iltsbilitles Basic financial liabilities, including creditor5 and bank loan5 are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument ¢5 measured at the prpsent value of the future payments discounted at a market rate of interest. Financial liabilities classifi'ed as payable within one year are not amortised. Debt instruments are subsequently carried at amortised CDSt, using the effective interest rate method. Trade creditor5 are obligation5 to pay for goods or servites that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if p3yment is due within one year or less. If not, they are presented as non-current liabilities. Tr3de creditors are recognised initially at transattion price and subsequently measured at amortised c05t using the effective interest method. Derecognition offinonclal liabilities Financial liabilities are derecognised when the Chariws contractual obligations expire or are discharged or cancelled. 1.9 Employee benefits The cost of any unused holiday entitlement is recognised in the period in which the employee's services are received. Termination benefits arÈ rècognised immediately as an expense when the Charity is demonstrablv committed to terminate the employment of an employee or to provide termination benefi'ts, 1.10 Retirement benefTts Payments to detined contribution retirement benefit schemes are charged as an expense as they fall due. Crltical accounting estimates and judgements In the application of the Charity's accounting policies, the Trustees are required to make judgemtS, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and 3ssociated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basi5. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the per iod of the revision and future periods where the revision affects both current and future periods. 12-
SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES NOTES TO THE FINANCIAL STATEMENTS ICONTINUEDJ FOR THE YEAR ENDED 31 DECEMBER 2024 Doftatfons and le8a¢ies Unrestrlrted Unrestricted funds funds genernl general 2024 2023 Donations and gifts Other fundraising and 5pon50rship 6,492 7,576 11,603 5,636 Income from charitable activities Unrestrirted funds 2024 Unrestricted funds 2023 Charltable attivtties Grants and other income 89,674 103.667 Income from investments Unrestrirted Unrestricted fund5 funds 2024 2023 Interest receivable 3,233 653 13
SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES NOTES TO THE FINANCIAL STATEMENTS (CONTINUEDI FOR THE YEAR ENDED 31 DECEMBER 2024 Expendlture on charitable a¢tlvltles Unrestrirted Unrestrlrted funds funds 2024 2023 Direct costs Staff costs Printing, postage and stationery Recharges Fundraising expense5 36,609 673 6,237 216 34,857 6,619 4,800 786 43,735 47,062 Share of support and governance costs (see note 7 Support Governance 30,590 1,820 30.420 1.820 76.145 79,302 Analysis by fund Unrestricted funds 76,145 79,302 Support costs allocated to activities 2024 2023 Staff costs Rent Sundries Insurance Consultancy fees Professional fees Governante costs 10,868 9,000 407 10,711 9,000 435 1,294 8,640 340 1,335 8.640 340 1,820 1,820 32,410 32,240 Analysed between: Unrestricted f unds 32,410 32,240 14-
SYNCOPE TRusf AND REFLEX ANOXIC SEIZURES NOTES TO THE FINANCIAL STATEMENTS {CONTINUED} FOR THE YEAR EhlDED 31 DECEMBER 2024 Net movement In funds 2024 2023 The net movement in funds is stated after chargingllcreditingl: Fees payable for the independent examination of the charity's ftnancial statements 1,820 1,820 Employees The average monthly number of employees during the year was: 2024 Number 2023 Number Employment cost5 2024 2023 Wages 2 nd salaries Social security costs Other pension costs 31,774 3,756 1,079 39,060 3.361 816 36.609 43,308 There were no employees whose annual remuneration was more than £60,000. 10 Trustees fumuneration and benefits There were no trustees, remuneratltsn or other benefits for the year ended 31 December 2024 nor for the year ended 31 December 2023. Trustees, expense5 There were no trustees, expenses paid for the year ended 31 December 2024 nor for the year ended 31 December 2023. 11 Taxatlon The charity is exempt from taxation on its activities because all its income is applied for charitable purposes. 15-
SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES NOTES TO THE FINANCIAL STATEMENTS (CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2024 12 Tangible fixed asset5 Ftxtures and Cost At l January 2024 15,895 At 31 December 2024 15,895 Depreciation and Impairment At l January 2024 15.895 At 31 December 2024 15.895 Carrying amount 13 Debtors 2024 2023 Amounts falling due within one year: Other debtors Prepayments and accrued income 78,992 336 540.053 326 79,328 540,379 14 Creditors: amounts falling due within one year 2024 2023 Other creditors Accruals and deferred income 1,778 1,680 1,976 1,680 3,458 3,656 15 Retirement benefit schemes 2024 2023 Defined contrlbution schemes Charge to profit Of loss in respect of defined contributlon schemes 1,079 816 16.
SYNCOPE TRUST AND REFLEX ANOXIC SEIZURES NOTES TO THE FINANCIAL STATEMENTS {CONTINUED} FOR THE YEAR ENDED 31 DECEMBER 2024 IS Retirement benefit schemes Icontinuedl The Charity operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the Charity in an independently administered fund. 16 Unrestricted funds The unrestricted funds of the charity comprise the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors a5 to how they may be used. These include designated funds which have been Set aside out of unrestricted funds by the trustees for specific purposes. At l January 2024 Incoming resources Resources expended At31 December 2024 General fund5 605,320 106,975 176,1451 636.150 Previous year: At l January 2023 In¢omlng resources Resource5 expended At31 December 2023 General f unds 563,063 121.559 179,3021 605,320 17 Related party transartion5 There were no disclosable related party transactions during the year12023 ~ none). 18 Transactions with connected charlties During the year, the charity was recharged £6,237 (2023: £4,800) by Arrhythmia Alliance IAAI, charity number 1107496 for costs incurred on its behalf. Repaying of Services was apportioned from AA of £52,924 12023: £85,417}. At the year end, there was a balance due from this charity of £46,689 (2023- £411,315). During the year, the charity recharge £25,560 {2023'. £25,790) for salary costs incurred on behalf of Atrial Fibrillatron Association, charity number 1122442. At the year end, there was a balance due from this charity of £25,560 {2023-, £121,7581. 17